ArticleEuropean journal of nuclear medicine and molecular imaging2019
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
Cristina Müller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
120 papers cite itlatest 60 shown
this paperpooled itcites it